Sodium butyrate, a histone deacetylase inhibitor, reverses behavioral and mitochondrial alterations in animal models of depression induced by early- or late-life stress

Current Neurovascular Research

Volumn 12, Issue 4, 2015, Pages 312-320

  Valvassori, Samira S ^a   Resende, Wilson R ^a   Budni, Josiane ^a   Dal Pont, Gustavo C ^a   Bavaresco, Daniela V ^a   Réus, Gislaine Z ^a   Carvalho, André F ^c   Gonçalves, Cinara L ^a   Furlanetto, Camila B ^a   Streck, Emilio L ^a   Quevedo, João ^a,b  

^a UNIVERSIDADE DO EXTREMO SUL CATARINENSE   (Brazil)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c Federal University of Ceará   (Brazil)

Author keywords

Chronic mild stress; Major depression; Maternal deprivation; Mitochondria; Sodium butyrate

Indexed keywords

BUTYRIC ACID; MALATE DEHYDROGENASE; SODIUM CHLORIDE; SUCCINATE DEHYDROGENASE; WATER; HISTONE DEACETYLASE INHIBITOR; MULTIENZYME COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CITRIC ACID CYCLE; CONTROLLED STUDY; CORPUS STRIATUM; DEPRESSION; DRUG EFFECT; EARLY LIFE STRESS; ENZYME ACTIVITY; EXPERIMENTAL BEHAVIORAL TEST; FEMALE; FOOD DEPRIVATION; FORCED SWIM TEST; IMMOBILIZATION STRESS; LATE LIFE STRESS; LIFE STRESS; LIGHT; MALE; MATERNAL DEPRIVATION; MITOCHONDRION; MOTHER; NONHUMAN; PERINATAL PERIOD; PRIORITY JOURNAL; RAT; SOCIAL ISOLATION; WATER DEPRIVATION; WISTAR RAT; ANIMAL; COMPLICATION; DISEASE MODEL; DRUG EFFECTS; EXPLORATORY BEHAVIOR; GENE EXPRESSION REGULATION; MENTAL STRESS; METABOLISM; NEWBORN; PATHOLOGY; PSYCHOLOGY; SWIMMING; TONIC IMMOBILITY;

ANIMALS; ANIMALS, NEWBORN; BUTYRIC ACID; CITRIC ACID CYCLE; CORPUS STRIATUM; DEPRESSION; DISEASE MODELS, ANIMAL; ELECTRON TRANSPORT CHAIN COMPLEX PROTEINS; EXPLORATORY BEHAVIOR; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HISTONE DEACETYLASE INHIBITORS; IMMOBILITY RESPONSE, TONIC; MALATE DEHYDROGENASE; MALE; MATERNAL DEPRIVATION; RATS; RATS, WISTAR; STRESS, PSYCHOLOGICAL; SUCCINATE DEHYDROGENASE; SWIMMING;

EID: 84942121169     PISSN: 15672026     EISSN: 18755739     Source Type: Journal    
DOI: 10.2174/1567202612666150728121121     Document Type: Article

References (83)

1. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, Gold SJ, Monteggia LM. Neurobiology of depression. Neuron 2002; 28; 34 (1): 13-25
2. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008; 455 (7215):894-902
3. Sharp C, Kim S, Herman L, Pane H, Reuter T, Strathearn L. Major depression in mothers predicts reduced ventral striatum activation in adolescent female offspring with and without depression. J Abnorm Psychol 2014; 123 (2): 298-309.
4. Diener C1, Kuehner C, Brusniak W, Ub B, Wessa M, Flor H. A meta-analysis of neurofunctional imaging studies of emotion and cognition in major depression. Neuroimage 2012; 3: 677-685.
5. Folstein MF, Robinson R, Folstein S, Mchugh PR. Depression and neurological disorders. New treatment opportunities for elderly depressed patients. J Affect Disord.Suppl 1985; Suppl 1: S11-4.
6. Thase M, Howland R, Friedman E. Treating antidepressant nonresponders with augmentation strategies: an overview. J Clin Psychiatry 1998; Suppl 5: 5-12; discussion 13-5.
7. Nelson C. Managing treatment resistant major depression. J Clin Psychiatry 2003; 64 Suppl 1:5-12.
8. Stahl SM. Stahl's Essential Psychopharmacology, 4th ed. Cambridge University Press. New York 2013.
9. Lin H, Geng X, Dang W, et al. Molecular mechanisms associated with the antidepressant effects of the class I histone deacetylase inhibitor MS-275 in the rat ventrolateral orbital cortex. Brain Res 2012; 1447: 119-125
10. Resende WR, Valvassori SS, Réus GZ, et al. Effects of sodium butyrate in animal models of mania and depression: implications as a new mood stabilizer. Behav Pharmacol 2013; 24 (7): 569-579.
11. Han A, Sung YB, Chung SY, Kwon MS. Possible additional antidepressant- like mechanism of sodium butyrate: Targeting the hippocampus. Neuropharmacology 2014; 81: 292-302.
12. Gurvich N, Berman MG, Wittner BS, Gentleman RC, Klein PS, Green JB. Association of valproate-induced teratogenesis with histone deacetylase inhibition in vivo. FASEB J 2005; 19 (9): 1166-1168.
13. Machado-Vieira R, Kapczinski F, Soares JC. Perspectives for the development of animal models of bipolar disorder.Prog Neuropsychopharmacol Biol Psychiatry 2004; 28 (2): 209-224.
14. Arent CO, Valvassori SS, Fries GR, et al. Neuroanatomical profile of antimaniac effects of histone deacetylases inhibitors. Mol Neurobiol 2011; 43 (3): 207-214.
15. Moretti M, Valvassori SS, Varela RB, et al. Behavioral and neurochemical effects of sodium butyrate in an animal model of mania. Behav Pharmacol 2011; 22 (8): 766-772.
16. Shao WH, Chen JJ, Fan SH, et al. Combined Metabolomics and Proteomics Analysis of Major Depression in an Animal Model: Perturbed Energy Metabolism in the Chronic Mild Stressed Rat Cerebellum. OMICS 2015; 19 (7): 383-392.
17. Valvassori SS, Calixto KV, Budni J, et al. Sodium butyrate reverses the inhibition of Krebs cycle enzymes induced by amphetamine in the rat brain. J Neural Transm 2013; 120 (12): 1737-1742.
18. Kato T, Kato N. Mitochondrial dysfunction in bipolar disorder. Bipolar Disord 2000; 2 (3Pt1): 180-190.
19. Lucca G, Comim CM, Valvassori SS, et al. Effects of chronic mild stress on the oxidative parameters in the rat brain. Neurochem Int 2009; 54 (5-6): 358-362
20. Rezin GT, Amboni G, Zugno AI, Quevedo J, Streck EL. Mitochondrial dysfunction and psychiatric disorders. Neurochem Res 2009; 34 (6): 1021-1029
21. Gardner A, Boles RG. Beyond the serotonin hypothesis: mitochondria, inflammation and neurodegeneration in major depression and affective spectrum disorders. Prog.Neuropsychopharmacol Biol Psychiatry 2011; 35 (3): 7307-7343.
22. Maes M, Fišar Z, Medina M, Scapagnini G, Nowak G, Berk M. New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates-Nrf2 activators and GSK-3 inhibitors. Inflammopharmacology 2012. 20 (3): 127-150.
23. Dias N, Bailly C. Drugs targeting mitochondrial functions to control tumor cell growth. Biochem Pharmacol 2005; 70 (1): 1-12.
24. Simpson PB, Russell JT. Role of mitochondrial Ca2+ regulation in neuronal and glial cell signaling. Brain Res Rev 1997; 26 (1): 72-81.
25. Brookes PS, Yoon Y, Robotham JL, Anders MW, Sheu SS. Calcium, ATP, and ROS: a mitochondrial love-hate triangle. Am J Physiol Cell Physiol 2004; 287 (4): 817-833.
26. Oyedotun KS, Lemire BD. The quaternary structure of the Saccharomyces cerevisiae succinate dehydrogenase.Homology modeling, cofactor docking, and molecular dynamics simulation studies. J Biol Chem 2004; 279 (10): 9424-9431
27. Kantorovich V, Pacak K. Pheochromocytoma and paraganglioma. Prog Brain Res 2010; 182: 343-373
28. Minard KI, McAlister-Henn L. Isolation, nucleotide sequence analysis, and disruption of the MDH2 gene from Saccharomyces cerevisiae: evidence for three isozymes of yeast malate dehydrogenase. Mol Cell Biol 1991; 11 (1): 370-380.
29. Vazquez V, Farley S, Giros B, Daugé V. Maternal deprivation increases behavioural reactivity to stressful situations in adulthood: suppression by the CCK2 antagonist L365, 260. Psychopharmacology 2005; 181: 706-713.
30. Willner P. Chronic mild stress (CMS) revisited: consistency and behavioural-neurobiological concordance in the effects of CMS. Neuropsychobiology 2005; 52 (2): 90-110.
31. Della FP, Abelaira HM, Réus GZ, et al. Treatment with tianeptine induces antidepressive-like effects and alters the neurotrophin levels, mitochondrial respiratory chain and cycle Krebs enzymes in the brain of maternally deprived adult rats. Metab Brain Dis 2013; 28 (1): 93-105.
32. Möller M, Du Preez JL, Viljoen FP, Berk M, Emsley R, Harvey BH. Social isolation rearing induces mitochondrial, immunological, neurochemical and behavioural deficits in rats, and is reversed by clozapine or N-acetyl cysteine. Brain Behav Immun 2013; 30: 156-167.
33. Gamaro GD, Manoli LP, Torres IL, Silveira R, Dalmaz C. Effects of chronic variate stress on feeding behavior and on monoamine levels in different rat brain structures. Neurochem Int 2003; 42 (2): 107-114.
34. Mello PB, Benetti F, Cammarota M, Izquierdo I. Physical exercise can reverse the deficit in fear memory induced by maternal deprivation. Neurobiol Learn Mem 2009; 92 (3): 364-369.
35. Kosten TA, Lee HJ, Kim JJ. Early life stress impairs fear conditioning in adult male and female rats.. Brain Res 2006; 1087 (1): 142-1450.
36. Porsolt RD, Le Pichon M, Jalfre M. Depression: a new animal model sensitive to antidepressant treatments. Nature 1977; 266 (5604): 730-732.
37. Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology 1995; 121 (1): 66-72.
38. Paxinos G, Watson C. The Rat Brain in Stereotaxic Coordinates Academic Press, San Diego 1986.
39. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193 (1): 265-275.
40. Kitto GB. Intra- and extramitochondrial malate dehydrogenases from chicken and tuna heart. Methods in Enzymology 1969; 23: 106-116.
41. Fischer JC, Ruitenbeek W, Berden JA, et al. Differential investigation of the capacity of succinate oxidation in human skeletal muscle. Clin Chim Acta 1985; 153 (1): 23-36.
42. Cassina A, Radi R. Differential inhibitory action of nitric oxide and peroxynitrite on mitochondrial electron transport. Arch Biochem Biophys 1996; 328 (2): 309-136.
43. Rustin P, Chretien D, Bourgeron T, et al. Biochemical and molecular investigations in respiratory chain deficiencies. Clin Chim Acta 1994; 228 (1): 35-51.
44. Yamawaki Y, Fuchikami M, Morinobu S, Segawa M, Matsumoto T, Yamawaki S. Antidepressant-like effect of sodium butyrate (HDAC inhibitor) and its molecular mechanism of action in the rat hippocampus. World J Biol Psychiatry 2012; 13 (6): 458-467.
45. Zhu H, Huang Q, Xu H, Niu L, Zhou JN, Antidepressant-like effects of sodium butyrate in combination with estrogen in rat forced swimming test: involvement of 5-HT(1A) receptors. Behav Brain Res 2009; 196 (2): 200-206
46. Fuchikami M, Yamamoto S, Morinobu S, Okada S, Yamawaki Y, Yamawaki S. The potential use of histone deacetylase inhibitors in the treatment of depression. Prog Neuropsychopharmacol Biol Psychiatry 2015; 278-5846(15)00059-7.
47. Phiel CJ, Zhang F, Huang EY, Guenther MG, Lazar MA, Klein PS. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. J Biol Chem 2001; 276 (39): 36734-36741.
48. Kouzarides T. Snap Shot: Histone-modifying enzymes. Cell 2007; 131 (4): 822.
49. Xu F, Zhang Q, Zhang K, Xie W, Grunstein M. Sir2 deacetylates histone H3 lysine 56 to regulate telomeric heterochromatin structure in yeast. Mol Cell 2007; 27 (6): 890-900.
50. Vieta E, Valentí M. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis. CNS Drugs 2013; 27 (7): 515-29.
51. Geddes JR, Miklowitz DJ. Treatment of bipolar disorder. Lancet 2013; 381 (9878): 1672-1682.
52. Castrén E, Rantamäki T. The role of BDNF and its receptors in depression and antidepressant drug action: Reactivation of developmental plasticity. Dev Neurobiol 2010; 70 (5): 289-297.
53. Yan HC, Cao X, Gao TM, Zhu XH. Promoting adult hippocampal neurogenesis: a novel strategy for antidepressant drug screening. Curr Med Chem 2011; 18 (28): 4359-4367.
54. Dell'Osso B, D'Addario C, Carlotta Palazzo M, et al. Epigenetic modulation of BDNF gene: differences in DNA methylation between unipolar and bipolar patients. J Affect Disord 2014; 166: 330-333.
55. Tunca Z, Ozerdem A, Ceylan D, et al. Alterations in BDNF (brainderivedneurotrophic factor) and GDNF (glialcell linederivedneurotrophic factor) serum levels in bipolar disorder: The role of lithium. J Affect Disord 2014; 166: 193-200.
56. Yoshimura R, Kishi T, Hori H, et al. Serum pro BDNF/BDNF and response to fluvoxamine in drug-naïve first-episode major depressive disorder patients. Ann Gen Psychiatry 2014; 9: 13-9.
57. Authement ME, Kodangattil JN, Gouty S, et al. Histone Deacetylase Inhibition Rescues Maternal Deprivation-Induced GABAergic Metaplasticity through Restoration of AKAP Signaling. Neuron. 2015; 86 (5): 1240-1252.
58. Dacher M, Nugent FS. Morphine-induced modulation of LTD at GABAergic synapses in the ventral tegmental area. Neuropharmacology. 2011; 61 (7): 1166-1171.
59. Jurado S, Biou V, Malenka RC. A calcineurin/AKAP complex is required for NMDA receptor-dependent long-term depression. Nat Neurosci 2010; 13 (9): 1053-1055
60. Lu M, Allen AR, Halt M, et al. Age-dependent requirement of AKAP150-anchored PKA and GluR2-lacking AMPA receptors in LTP. EMBO J 2007; 26 (23): 4879-4890.
61. Lu Y1, Allen M, Halt AR, et al. AKAP150-anchored PKA activity is important for LTD during its induction phase. J. Physiol 2007; 26 (23): 4879-4890.
62. Sanderson JL, Gorski JA, Gibson ES, et al. AKAP150-anchored calcineurin regulates synaptic plasticity by limiting synaptic incorporation of Ca2+-permeable AMPA receptors. J Neurosci 2012; 32 (43): 15036-15052.
63. Choi MC, Jong HS, Kim TY, Song SH, et al. AKAP12/Gravin is inactivated by epigenetic mechanism in human gastric carcinoma and shows growth suppressor activity. Oncogene 2004; 23 (42): 7095-7103.
64. Reissner KJ, Uys JD, Schwacke JH, et al. AKAP signaling in reinstated cocaine seeking revealed by iTRAQ proteomic analysis. J Neurosci 2011; 31 (15): 5648-5658.
65. Blass JP, Brown AM. Lower activity of Krebs cycle enzymes than of electron transport in human brain: disease implications. Neurobiol Aging 2000; 21, 81.
66. Armstrong JS. The role of the mitochondrial permeability transition in cell death. Mitochondrion 2006; 6 (5): 225-234.
67. Naoi M, Maruyama W, Shamoto-Nagai M, et al. Oxidative stress in mitochondria: decision to survival and death of neurons in neurodegenerative disorders. Mol Neurobiol 2005; 31 (1-3): 81-93.
68. Schapira AH. Mitochondrial disease. Lancet 2006; 368 (9529): 70-82.
69. Cáceda R, Gamboa JL, Boero JA, Monge-C C, Arregui A. Energetic metabolism in mouse cerebral cortex during chronic hypoxia. Neurosci Lett 2001; 301 (3): 171-174.
70. Rezin GT, Gonçalves CL, Daufenbach JF, et al. Acute administration of ketamine reverses the inhibition of mitochondrial respiratory chain induced by chronic mild stress. Brain Res Bull 2009; 79 (6): 418-421.
71. Hroudová J, Fišar Z, Kitzlerová E, Zvěřová M, Raboch J. Mitochondrial respiration in blood platelets of depressive patients. Mitochondrion 2013; 13 (6): 795-800.
72. Beal MF. Mitochondria and neurodegeneration. Novartis Found Symp 2007; 287: 183-192.
73. Diehl LA, Alvares LO, Noschang C, et al. Long-lasting effects of maternal separation on an animal model of post-traumatic stress disorder: effects on memory and hippocampal oxidative stress. Neurochem Res 2012; 4: 700-707.
74. Schiavone S, Jaquet V, Trabace L, Krause KH. Severe life stress and oxidative stress in the brain: from animal models to human pathology. Antioxid Redox Signal 2013; 18 (12): 1475-1490.
75. Bhatt S, Radhakrishnan M, Jindal A, Devadoss T, Dhar AK. Neuropharmacological evaluation of a novel 5-HT3 receptor antagonist (6g) on chronic unpredictable mild stress-induced changes in behavioural and brain oxidative stress parameters in mice. Indian J Pharmacol 2014; 46 (2): 191-196.
76. Abelaira HM, Réus GZ, Ribeiro KF, et al. Effects of lamotrigine on behavior, oxidative parameters and signaling cascades in rats exposed to the chronic mild stress model. Neurosci Res 2013; 75 (4): 324-330.
77. Mrdalj J, Pallesen S, Milde AM, et al. Early and later life stress alter brain activity and sleep in rats. PLoS One 2013; 8 (7): 69923.
78. Ignacio ZM, Reus GZ, Abelaira HM, et al. Acute and chronic treatments with quetiapine increase mitochondrial respiratory chain complex activity in the rat brain. Curr Neurovasc Res. 2015.
79. de Sousa RT, Streck EL, Zanetti MV, et al. Lithium increases leukocyte mitochondrial complex I activity in bipolar disorder during depressive episodes. Psychopharmacology (Berl) 2015; 232 (1): 245-250.
80. Steckert AV, Valvassori SS, Varela RB, et al. Effects of sodium butyrate on oxidative stress and behavioral changes induced by administration of D-AMPH. Neurochem Int 2013; 62 (4): 425-432.
81. Beal MF. Mitochondria, free radicals, and neurodegeneration. Curr Opin Neurobiol 1996; 6 (5): 661-666.
82. Bogdanova OV, Kanekar S, D'Anci KE, Renshaw PF. Factors influencing behavior in the forced swim test. Physiol Behav 2013; 118: 227-239.
83. Chen F, Wegener G, Madsen TM, Nyengaard JR. Mitochondrial plasticity of the hippocampus in a genetic rat model of depression after antidepressant treatment. Synapse 2013; 67 (3): 127-134.